Hikari Osaki

444 total citations
5 papers, 140 citations indexed

About

Hikari Osaki is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hikari Osaki has authored 5 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hikari Osaki's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Protein Degradation and Inhibitors (2 papers). Hikari Osaki is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Protein Degradation and Inhibitors (2 papers). Hikari Osaki collaborates with scholars based in United Kingdom, Netherlands and Australia. Hikari Osaki's co-authors include Owen Williams, R. Pieters, Ronald W. Stam, Dominique J. P. M. Stumpel, Pauline Schneider, Sarah J. Horton, Louise van der Weyden, Brian J.P. Huntly, George Giotopoulos and David J. Adams and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Leukemia.

In The Last Decade

Hikari Osaki

5 papers receiving 139 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hikari Osaki United Kingdom	5	93	67	47	19	16	5	140
Bruno A. Lopes Brazil	7	71 0.8×	54 0.8×	45 1.0×	18 0.9×	15 0.9×	20	126
Antonio Agraz-Doblás Spain	5	90 1.0×	62 0.9×	57 1.2×	29 1.5×	12 0.8×	7	138
Antonio Molinés Spain	5	101 1.1×	151 2.3×	90 1.9×	23 1.2×	22 1.4×	6	188
María José Sayas Spain	4	147 1.6×	155 2.3×	96 2.0×	22 1.2×	23 1.4×	8	202
Sorcha O’Byrne United Kingdom	4	90 1.0×	59 0.9×	28 0.6×	11 0.6×	8 0.5×	7	128
Valentina Robustelli Italy	6	63 0.7×	37 0.6×	28 0.6×	39 2.1×	10 0.6×	13	103
Aurélie Caye France	5	41 0.4×	75 1.1×	74 1.6×	7 0.4×	13 0.8×	8	118
Kazuki Terada Japan	4	55 0.6×	76 1.1×	32 0.7×	6 0.3×	14 0.9×	8	101
Kristen Meldi United States	4	112 1.2×	111 1.7×	15 0.3×	12 0.6×	41 2.6×	6	166
Olimpia Finizio Italy	7	83 0.9×	149 2.2×	65 1.4×	30 1.6×	18 1.1×	8	175

Countries citing papers authored by Hikari Osaki

Since Specialization

Citations

This map shows the geographic impact of Hikari Osaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hikari Osaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hikari Osaki more than expected).

Fields of papers citing papers by Hikari Osaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hikari Osaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hikari Osaki. The network helps show where Hikari Osaki may publish in the future.

Co-authorship network of co-authors of Hikari Osaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hikari Osaki. A scholar is included among the top collaborators of Hikari Osaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hikari Osaki. Hikari Osaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Weyden, Louise van der, George Giotopoulos, Kim Wong, et al.. (2015). Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5 +/− leukemia. BMC Cancer. 15(1). 585–585. 21 indexed citations

2.

Giotopoulos, George, Louise van der Weyden, Hikari Osaki, et al.. (2015). A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression. The Journal of Experimental Medicine. 212(10). 1551–1569. 23 indexed citations

3.

Osaki, Hikari, Li Zhao, Sarah J. Horton, et al.. (2013). The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis. Leukemia. 27(7). 1461–1468. 30 indexed citations

4.

Stumpel, Dominique J. P. M., Pauline Schneider, Hikari Osaki, et al.. (2011). Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia. Leukemia. 26(4). 682–692. 62 indexed citations

5.

Stumpel, Dominique J. P. M., Pauline Schneider, Hikari Osaki, et al.. (2010). Connectivity Mapping Identifies HDAC Inhibitors as Suitable Candidates for the Treatment of t(4;11)-Positive Acute Lymphoblastic Leukemia In Infants. Blood. 116(21). 3222–3222. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact